| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $302.4M | -15.5% |
| Cost of Revenue | $249.1M | -15.0% |
| Gross Profit | $53.3M | -17.5% |
| R&D Expense | $1.9M | +11.8% |
| SG&A Expense | $36.6M | -3.7% |
| Operating Income | $16.7M | -37.1% |
| Interest Expense | -$193K | -119.1% |
| Pre-tax Income | $17.5M | -32.1% |
| Income Tax | $4.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.8M | +73.4% |
| Accounts Receivable | $30.1M | -27.8% |
| Inventory | $18.3M | -16.8% |
| Current Assets | $102.9M | +0.0% |
| Total Assets | $209.6M | -1.8% |
| Current Liabilities | $36.7M | -20.5% |
| Long-term Debt | $19.7M | -8.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.2M | +0.9% |
| Capital Expenditures | $11.5M | +26.6% |
| Investing Cash Flow | -$11.5M | -26.6% |
| Financing Cash Flow | -$5.9M | -1.8% |
| Free Cash Flow | $23.6M | -8.2% |
| -22.9% |
| Net Income | $13.3M | -34.6% |
| EPS (Basic) | $1.53 | -35.4% |
| EPS (Diluted) | $1.51 | -34.6% |
| Total Liabilities |
| $62.2M |
| -16.4% |
| Stockholders' Equity | $147.4M | +6.1% |